0001415889-25-021693.txt : 20250813 0001415889-25-021693.hdr.sgml : 20250813 20250813210933 ACCESSION NUMBER: 0001415889-25-021693 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20250811 FILED AS OF DATE: 20250813 DATE AS OF CHANGE: 20250813 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Hill Stephen J. CENTRAL INDEX KEY: 0001866154 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40502 FILM NUMBER: 251213832 MAIL ADDRESS: STREET 1: C/O LYELL IMMUNOPHARMA, INC. STREET 2: 400 EAST JAMIE COURT, SUITE 301 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Lyell Immunopharma, Inc. CENTRAL INDEX KEY: 0001806952 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences EIN: 833006753 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 201 HASKINS WAY CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 650 695-0677 MAIL ADDRESS: STREET 1: 201 HASKINS WAY CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 4 1 form4-08142025_010830.xml X0508 4 2025-08-11 0001806952 Lyell Immunopharma, Inc. LYEL 0001866154 Hill Stephen J. C/O LYELL IMMUNOPHARMA, INC. 201 HASKINS WAY SOUTH SAN FRANCISCO CA 94080 false true false false Chief Operating Officer 0 Common Stock 2025-08-11 4 S 0 91 10.526 D 8943 D Common Stock 2025-08-12 4 S 0 94 10.338 D 8849 D Shares automatically sold to cover tax withholding obligation from settlement of vested restricted stock units. The price reported above reflects the weighted average price of the shares sold. The sale price ranged from $10.045 to $11.00 per share. Upon request from the SEC staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Includes 390 shares acquired on May 18, 2025 under the Issuer's 2021 Employee Stock Purchase Plan. On May 30, 2025, the Issuer effected a 1-for-20 reverse stock split of its common stock. All share and amounts reported herein reflect the reverse stock split. Shares automatically sold to cover tax withholding obligation from settlement of vested restricted stock units. The price reported above reflects the weighted average price of the shares sold. The sale price ranged from $10.120 to $10.415 per share. Upon request from the SEC staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. On May 30, 2025, the Issuer effected a 1-for-20 reverse stock split of its common stock. All share and amounts reported herein reflect the reverse stock split. /s/ Allison Peth, Attorney-in-Fact 2025-08-13